Angioplasty Balloons Market Size To Reach $3.4 Billion By 2030

Angioplasty Balloons Market Growth & Trends

The global angioplasty balloons market size is expected to reach USD 3.4 billion in 2030 and is projected to grow at a CAGR of 3.8% from 2025 to 2030, according to a new report by Grand View Research, Inc. This growth is attributed to favorable government policies and increasing coronary and peripheral interventions. Angioplasty is a minimally invasive procedure, hence patients and surgeons prefer this procedure over high-cost stent placements. Furthermore, advancements in angioplasty balloons and expanding geographical reach are likely to propel the market growth in the coming years.

For instance, in December 2014, Medtronic plc received an FDA approval for their drug-coated balloon IN.PACT Admiral for the treatment of peripheral artery disease. The company also received product approval from Japanese Ministry of Health, Labor and Welfare for the treatment of peripheral artery disease in the upper leg. Approval and commercialization of cutting and scoring balloons, such as TREK and MINI TREK, AngioSculpt, and Flextome balloons along with rising adoption of new balloons are likely to drive the market further.

 Request a free sample copy or view report summary: Angioplasty Balloons Market Report

Angioplasty Balloons Market Report Highlights

• The normal balloons segment held the largest market share of 53.8% in 2024 due to low costs and ability of these products to treat coronary artery obstruction

• DEBs are anticipated to be the fastest-growing segment during the forecast period due to lower restenosis rate and increased R&D investments by major companies

• In 2024, coronary vascular diseases segment held the largest market share of 53.4% due to the high incidence of coronary artery diseases, which are the most common type of all heart diseases

• The ambulatory surgery centers segment dominated the market with a share of 38.8% in 2024, due to the huge demand for treatments in these settings.

• North America angioplasty balloons market held a significant position in the global market in 2024, with a share of 39.1%. North America has been a dominant region in the angioplasty balloons market, driven by advanced healthcare infrastructure, high healthcare spending, and a growing elderly population

Angioplasty Balloons Market Segmentation

Grand View Research has segmented the global angioplasty balloons market report based on product, application, end use, and region:

Angioplasty Balloons Product Outlook (Revenue, USD Million, 2018 - 2030)

• Normal Balloons

• Drug Coated Balloons

• Cutting Balloons

• Scoring Balloons

Angioplasty Balloons Application Outlook (Revenue, USD Million, 2018 - 2030)

• Peripheral Vascular Diseases

• Coronary Vascular Diseases

Angioplasty Balloons End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Ambulatory Surgical Centers

• Hospitals

• Cath Labs

Angioplasty Balloons Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Sweden

  • Norway

  • Denmark

• Asia Pacific

  • China

  • Japan

  • India

  • Australia

  • Thailand

  • South Korea

• Latin America

  • Brazil

  • Argentina

• Middle East and Africa

  • Saudi Arabia

  • South Africa

  • UAE

  • Kuwait

List of Key Players in the Angioplasty Balloons Market

• Medtronic

• Boston Scientific Corporation

• Johnson & Johnson Services, Inc.

• Abbott

• C. R. Bard, Inc.

• Spectranetics

• Terumo Medical Corporation

• Cardinal Health

• BIOTRONIK

• Cook Medical

• ENDOCOR GmbH

• B. Braun SE